Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Palavras-chave: HER2, silver in situ hybridization, SISH, fluorescence in situ hybridization, FISH,
breast carcinoma, immunohistochemistry
Arnould L, Arveux P, Couturier J, et al. Pathologic complete Sauter G, Lee J, Bartlett JM, et al. Guidelines for human
response to Trastuzumab-based neoadjuvant therapy is epidermal growth factor receptor 2 testing: biologic and
related to the level of HER-2 amplification. Clin Cancer Res. methodologic considerations. J Clin Oncol. 2009;27:1323
2007; 13; 6404-6409 1333
Baselga J, Norton L, Albanell M, et al. Recombinant Schechter AL, Stern DF, Vaidyanathan L, et al. The neu
humanized anti-HER2 antibody (Herceptin) enhances the oncogene: an erb-Brelated gene encoding a 185,000-Mr
antitumor activity of Paclitaxel and doxorubicin against tumour antigen. Nature 1984;312:513-6.
HER2/neu overexpressing human breast cancer xenografts.
Cancer Res. 1998;58: 28252831. Seshadri R, Horsfall DJ, Firgaira F, et al. The relative
prognostic significance of total cathepsin D and HER-2/neu
Bacus SS, Zelnick CR, Plowman G, Yarden Y. Expression of oncogene amplification in breast cancer. The South
the erbB-2 family of growth factor receptors and their ligands Australian Breast Cancer Study Group. Int J Cancer
in breast cancers. Implication for tumor biology and clinical 1994;56:61-5.
behavior. Am J Clin Pathol 1994;102:S13-24
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A,
Cuadros M, Villegas R. Systematic review of HER2 breast McGuireWL. Human breast cancer: correlation of relapse
cancer testing. Appl Immunohistochem Mol Morphol. 2009 and survival with amplification of the HER-2/neu oncogene.
Jan; 17(1):1-7. Science 1987;235: 177-82
Dendukuri N, Khetani K, McIsaac M, et al. Testing for Slamon D, Godolphin W, Jones LA, et al. Studies of the
HER2-positive breast cancer: a systematic review and cost- HER-2/neu proto-oncogene in human breast and ovarian
effectiveness analysis. CMAJ. 2007 May; 176(10):1429-34. cancer. Science. 1989;244:707712.
Descotes F, Pavy JJ, Adessi GL. Human breast cancer: Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne
correlation study between HER-2/neu amplification and MP. HER-2/neu amplification and overexpression in primary
prognostic factors in an unselected population. Anticancer human breast cancer is associated with early metastasis.
Res 1993;13:119-24. Anticancer Res 1992;12:419-25.
Dietel M, Ellis IO, Hofler H, et al. Comparison of automated Zeillinger R, Kury F, Czerwenka K, et al. HER-2
silver enhanced in situ hybridization (SISH) and fluorescence amplification, steroid receptors and epidermal growth factor
ISH (FISH) for the validation of HER2 gene status in breast receptor in primary breast cancer. Oncogene 1989;4:109-14